SLC7A11 and cancer: Notably, sulfasalazine, a drug commonly prescribed for ulcerative colitis or rheumatoid arthritis, was recently found to act as a specific inhibitor of xCT‐mediated cystine transport and is now undergoing clinical trials for mono‐ and combination therapies against different types of cancer.10